Agnes Lee

15.5k total citations · 7 hit papers
137 papers, 9.4k citations indexed

About

Agnes Lee is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine and Emergency Medical Services. According to data from OpenAlex, Agnes Lee has authored 137 papers receiving a total of 9.4k indexed citations (citations by other indexed papers that have themselves been cited), including 114 papers in Internal Medicine, 78 papers in Cardiology and Cardiovascular Medicine and 60 papers in Emergency Medical Services. Recurrent topics in Agnes Lee's work include Venous Thromboembolism Diagnosis and Management (114 papers), Central Venous Catheters and Hemodialysis (60 papers) and Atrial Fibrillation Management and Outcomes (49 papers). Agnes Lee is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (114 papers), Central Venous Catheters and Hemodialysis (60 papers) and Atrial Fibrillation Management and Outcomes (49 papers). Agnes Lee collaborates with scholars based in Canada, United States and United Kingdom. Agnes Lee's co-authors include Mark N. Levine, Alok A. Khorana, Ajay K. Kakkar, Jim A. Julian, Michael Gent, Martin H. Prins, Chris Bowden, Frederick R. Rickles, Ross Baker and Michael J. Kovacs and has published in prestigious journals such as New England Journal of Medicine, JAMA and Circulation.

In The Last Decade

Agnes Lee

134 papers receiving 9.1k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer

2003 1.8k citations Agnes Lee, Mark N. Levine et al. profile →
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update

2019 934 citations Nigel S. Key, Alok A. Khorana et al. Journal of Clinical Oncology profile →
Venous Thromboembolism and Cancer: Risks and Outcomes

2003 556 citations Agnes Lee, Mark N. Levine profile →
American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer

2021 489 citations Gary H. Lyman, Marc Carrier et al. Blood Advances profile →
Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer

2015 452 citations Agnes Lee, Pieter W. Kamphuisen et al. profile →
Cancer-associated venous thromboembolism

2022 235 citations Alok A. Khorana, Anna Falanga et al. profile →
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Guideline Update

2023 135 citations Nigel S. Key, Alok A. Khorana et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Agnes Lee

Since Specialization

Citations

This map shows the geographic impact of Agnes Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Agnes Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Agnes Lee more than expected).

Fields of papers citing papers by Agnes Lee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Agnes Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Agnes Lee. The network helps show where Agnes Lee may publish in the future.

Co-authorship network of co-authors of Agnes Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Agnes Lee. A scholar is included among the top collaborators of Agnes Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Agnes Lee. Agnes Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	ABO blood group and COVID-19 severity: Associations with endothelial and adipocyte activation in critically ill patients 2025 ·PLoS ONE ·Sophie Stukas, George Goshua, Edward M. Conway, Agnes Lee, Ryan L. Hoiland, Mypinder S. Sekhon, Luke Y. C. Chen	0
2	Dual direct oral anticoagulant therapy in challenging thrombosis: a case series 2024 ·Research and Practice in Thrombosis and Haemostasis ·Nicholas L.J. Chornenki, (unknown), Erica A. Peterson, (unknown), Agnes Lee	1
3	Avoiding the needle: A quality improvement program introducing apixaban for extended thromboprophylaxis after major gynecologic cancer surgery 2024 ·Gynecologic Oncology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Agnes Lee, (unknown), Justin M. McGinnis	4
4	CRP and sCD25 help distinguish between adult‐onset Still's disease and HLH 2024 ·European Journal Of Haematology ·(unknown), (unknown), (unknown), John Wade, J. Antonio Aviña‐Zubieta, Audi Setiadi, Lori B. Tucker, Kam Shojania, (unknown), André Mattman, Agnes Lee, David C. Fajgenbaum, Luke Y. C. Chen	6
5	Risk of Recurrent Venous Thromboembolism in Patients with Cancer: An Individual Patient Data Meta-analysis and Development of a Prediction Model 2024 ·Thrombosis and Haemostasis ·(unknown), Toshihiko Takada, Floris T.M. Bosch, Andrea Marshall, Michael Grosso, Annie Young, Agnes Lee, Marcello Di Nisio, Gary E. Raskob, Pieter W. Kamphuisen, HR Büller, Nick van Es	2
6	Comparison of Clinical Outcomes in Patients with Active Cancer Receiving Rivaroxaban or Low-Molecular-Weight Heparin: The OSCAR-UK Study 2024 ·Thrombosis and Haemostasis ·Alexander T. Cohen, Christopher Wallenhorst, (unknown), Cihan Ay, (unknown), (unknown), (unknown), Gunnar Brobert, Anders Ekbom, Agnes Lee, Alok A. Khorana, Cecilia Becattini, Marc Carrier, Craig I Coleman, Carlos Martínez	3
7	Rivaroxaban versus Apixaban for Treatment of Cancer-Associated Venous Thromboembolism in Patients at Lower Risk of Bleeding 2023 ·SHILAP Revista de lepidopterología ·(unknown), Cecilia Becattini, Marc Carrier, Alexander T. Cohen, Anders Ekbom, Alok A. Khorana, Agnes Lee, (unknown), (unknown), (unknown), Marcela Rivera, (unknown), Gunnar Brobert, Craig I Coleman	6
8	Randomized trials of therapeutic heparin for COVID‐19: A meta‐analysis 2021 ·Research and Practice in Thrombosis and Haemostasis ·Michelle Sholzberg, Bruno R. da Costa, Grace H. Tang, Hassan Rahhal, Musaad AlHamzah, Lisa Baumann Kreuziger, Fionnuala Ní Áinle, (unknown), Paula James, David Lillicrap, Marc Carrier, Andrew Beckett, Michael Fralick, Saskia Middeldorp, Agnes Lee, Kevin E. Thorpe, Elnara Márcia Negri, Mary Cushman, Peter Jüni	30
9	American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer breakdown → 2021 ·Blood Advances ·Gary H. Lyman, Marc Carrier, Cihan Ay, Marcello Di Nisio, Lisa K. Hicks, Alok A. Khorana, Andrew D. Leavitt, Agnes Lee, Fergus Macbeth, Rebecca L. Morgan, Simon Noble, (unknown), David D. Stenehjem, Wojtek Wiercioch, Lara A Kahale, Pablo Alonso‐Coello	489
10	Treatment Algorithm in Cancer-Associated Thrombosis: Updated Canadian Expert Consensus 2021 ·Current Oncology ·Marc Carrier, Normand Blais, Mark Crowther, Petr Kavan, Grégoire Le Gal, Otto Moodley, Sudeep Shivakumar, Deepa Suryanarayan, Vicky Tagalakis, Cynthia Wu, Agnes Lee	31
11	Cancer‐associated venous thromboembolism: Treatment and prevention with rivaroxaban 2020 ·Research and Practice in Thrombosis and Haemostasis ·Rupert Bauersachs, Alok A. Khorana, Agnes Lee, Gerald A. Soff	8
12	Amelioration of COVID‐19‐related cytokine storm syndrome: parallels to chimeric antigen receptor‐T cell cytokine release syndrome 2020 ·British Journal of Haematology ·Ryan L. Hoiland, Sophie Stukas, Jennifer Cooper, Sonny Thiara, Luke Y. C. Chen, Catherine M. Biggs, Kevin A. Hay, Agnes Lee, Kam Shojania, (unknown), Cheryl L. Wellington, Mypinder S. Sekhon	28
13	Comparative effectiveness and safety of oral anticoagulants for atrial fibrillation: A retrospective cohort study 2020 ·PubMed ·Anne Holbrook, Richard L. Morrow, Agnes Lee, Gary Foster, (unknown)	4
14	Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update breakdown → 2019 ·Journal of Clinical Oncology ·Nigel S. Key, Alok A. Khorana, Nicole M. Kuderer, Kari Bohlke, Agnes Lee, Juan I. Arcelus, Sandra L. Wong, Edward P. Balaban, Christopher R. Flowers, Charles W. Francis, (unknown), Ajay K. Kakkar, Mark N. Levine, Howard A. Liebman, Margaret A. Tempero, Gary H. Lyman, Anna Falanga	934
15	COSIMO – patients with active cancer changing to rivaroxaban for the treatment and prevention of recurrent venous thromboembolism: a non-interventional study 2018 ·Thrombosis Journal ·(unknown), Alexander T. Cohen, Anthony Maraveyas, Jan Beyer‐Westendorf, Agnes Lee, LG Mantovani, (unknown)	20
16	Hemophagocytic syndromes (HPSs) including hemophagocytic lymphohistiocytosis (HLH) in adults: A systematic scoping review 2016 ·Blood Reviews ·Anna Hayden, Su‐Jin Park, Dean Giustini, Agnes Lee, Luke Y. C. Chen	204
17	Selective D-Dimer Testing for Diagnosis of a First Suspected Episode of Deep Venous Thrombosis 2013 ·Annals of Internal Medicine ·Lori‐Ann Linkins, Shannon M. Bates, Eddy Lang, Susan R. Kahn, James D. Douketis, Jim A. Julian, Sameer Parpia, Peter L. Gross, Jeffrey I. Weitz, Frederick A. Spencer, Agnes Lee, Martin O’Donnell, Mark Crowther, (unknown), Wendy Lim, Sam Schulman, Jeffrey S. Ginsberg, Clive Kearon	3
18	Venous thromboembolism in advanced disease : a clinical guide 2009 ·Oxford University Press eBooks ·Simon Noble, (unknown), Agnes Lee	2
19	VTE in Patients with Cancer-Diagnosis, Prevention, and Treatment 2008 ·Thrombosis Research ·Agnes Lee	18
20	Anti-Xa effect of a low molecular weight heparin (dalteparin) does not accumulate in extended duration therapy for venous thromboembolism in cancer patients 2005 ·Thrombosis and Haemostasis ·Mark Levine, Michael Keeney, Karen MacKinnon, Agnes Lee, Michael J. Kovacs	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact